MENU
CNSP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
CNS Pharmaceuticals (CNSP) Earnings Date & Reports
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology... Show more
A.I. Advisor
published Earnings
CNSP is expected to report earnings to fall 28.95% to -27 cents per share on March 03
Q4'26
Est.
$-0.27
Q2'26
Beat
by $0.31
Q1'26
Beat
by $0.31
Q4'25
Missed
by $9.17
Q3'25
Missed
by $5.13
The last earnings report on August 13 showed earnings per share of -37 cents, beating the estimate of -68 cents. With 5.52K shares outstanding, the current market capitalization sits at 6.82M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors.
Industry Biotechnology
Industry
N/A
Address
2100 West Loop South
Phone
+1 800 946-9185
Employees
8
Web
https://www.cnspharma.com